Neurodiagnostics Market.

Neurodiagnostics Market

Industry:

The goal of this section is to illustrate the opportunity and how a product can capture it. Requirements include:

– Delineate both current market size and how much you expect it to grow in the future. Also, you need to indicate what kind of market you are facing.

– Examine industry economics. For example, do companies within the industry enjoy strong gross and net income margin?

– Describe your overall market in terms of revenues, growth, and future needs that are pertinent.

The project belong to the Neurodiagnostics market, Neurotechnological industry which is a rapidly expanding, because actually neurological diseases and psychiatric illnesses represent:

• The largest and fastest growing unmet medical market: 2 billion people worldwide.
• The greatest potential for major scientific discoveries, commercial success and sustainable investment opportunities
• In 2006, venture capital investment in neurotechnology rose 7.5% to $1.67 billion.

CEREBRA operates in Taiwan, targeting neurological research communities in Asia. Plans to extend to clinical and home markets will target the medical and hospital communities across Asia.

The neurotechnological industry, faces new market opportunities: “The worldwide economic burden for brain-related illnesses reached more than $2 trillion per year in 2006; more than $1 trillion in the U.S. alone. This burden has increased the demand for neurological research and study”

The market is a crowded market with hundreds of companies, but few of these are producing technologies with device specifications comparable to CerebraTek.

The long-term outlook for the neurodiagnostic industry is to develop technology that leads the market. An establishment in the research market would offer low-risk high-margin opportunities while establishment in the clinical market is vital to creating future opportunities in clinical, point-of-care and home markets.

CerebraTek’s neurotechnological applications focused on treating brain and nervous system illnesses include pharmaceuticals, biologics, medical devices, software tools, diagnostic systems and surgical equipment for the treatment of neurological diseases, nervous systems injuries and psychiatric illnesses.

The Current trends of the market includes an aging population with increased incidents for neurological disorders as well as staffing decreases in clinics and medical facilities driving the need for superior equipment in EEG monitoring.

The market is segmented on the basis of 3 primary market segments: Neuroimaging market – in vitro diagnostics market – neuroinformatics market:

...